ClassID:

112268

C12N2820/007 - CPC Classification

Classification description:

Vectors comprising a special origin of replication system tissue or cell-specific

Recent Application in this class:
#1
20260022389
2026-01-22

SINGLE-VECTOR TYPE I VECTORS

#2
20250325709
2025-10-23

GENE DELIVERY TARGETING NEURAL STEM CELLS AND NEURAL PROGENITOR CELLS

#3
20250325707
2025-10-23

Solving Brain Circuit Function and Dysfunction With Computational Modeling and Optogenetic Functional Magnetic Resonance Imaging

#4
20250235493
2025-07-24

Recombinant Viral Genomes and Related Compositions and Methods

#5
20250223610
2025-07-10

MEASUREMENT OF SOMATIC L1 RETROTRANSPOSITION ACTIVITY

#6
20250197880
2025-06-19

ENGINEERED PHOSPHOENOLPYRUVATE CARBOXYLASE ENZYMES

#7
20250171775
2025-05-29

PROMOTERS FOR SPECIFIC EXPRESSION OF GENES IN CONE PHOTORECEPTORS

#8
20240150792
2024-05-09

Oncolytic Virus and Methods of Use

#9
20240141365
2024-05-02

SINGLE-VECTOR TYPE I VECTORS

#10
20230277686
2023-09-07

A NOVEL MUSCLE-SPECIFIC PROMOTER

#11
20230193317
2023-06-22

RNA-based delivery systems with levels of control

#12
20230089121
2023-03-23

NOVEL COMBINATION OF NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USES THEREOF

#13
20220145319
2022-05-12

Engineered phosphoenolpyruvate carboxylase enzymes

#14
20210189406
2021-06-24

Single-vector type I vectors

#15
20210163960
2021-06-03

Single-vector type I vectors

#16
20200140831
2020-05-07

Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy

#17
20200115716
2020-04-16

Single-vector type I vectors

#18
20200071723
2020-03-05

RNA-based delivery systems with levels of control

#19
20190183946
2019-06-20

ONCOLYTIC ADENOVIRUSES FOR CANCER TREATMENT

#20
20170152523
2017-06-01

Serum-free stable transfection and production of recombinant human proteins in human cell lines

#21
20170037406
2017-02-09

Pharmaceutical composition comprising Nanog shRNA, and method of using Nanog shRNA to treat cancer

#22
20170009252
2017-01-12

Vectors and methods for the efficient generation of integration/transgene-free induced pluripotent stem cells from peripheral blood cells

#23
20160354420
2016-12-08

Oncolytic adenoviruses for cancer treatment

#24
20160137988
2016-05-19

Cytochrome P450 enzymes from sorghum bicolor

#25
20160032290
2016-02-04

Pharmaceutical composition comprising Nanog shRNA, and method of using Nanog shRNA to treat cancer

#26
20160010113
2016-01-14

COMPOSITIONS AND METHODS FOR ENGINEERING CELLS

#27
20130315870
2013-11-28

Compositions and methods for retargeting virus constructs

#28
20130040304
2013-02-14

Compositions and Methods for Engineering Cells

#29
20110318367
2011-12-29

Targets for treatment of hypercholesterolemia

#30
20110263001
2011-10-27

Compositions and Methods for Engineering Cells

#31
20110214190
2011-09-01

TRANSGENIC REPORTER MOUSE AND METHOD FOR USE

#32
20100184141
2010-07-22

Serum-free stable transfection and production of recombinant human proteins in human cell lines

#33
20100122355
2010-05-13

Transgenic Reporter Mouse and Method for Use

#34
20100050276
2010-02-25

Transgenic non-human animal models of apoptosis-mediated conditions

#35
20090311219
2009-12-17

Oncolytic Adenoviruses for Cancer Treatment